Q3 2023 Results - Reimagining Medicine slide image

Q3 2023 Results - Reimagining Medicine

Company overview Financial review Innovation: Pipeline overview Financial performance Cardiovascular Immunology Ophthalmology Global Health Conclusions Neuroscience Appendix Innovation: Clinical trials Oncology Global Health References Abbreviations Other 80 Investor Relations | Q3 2023 Results 1 NOVARTIS | Reimagining Medicine
View entire presentation